The International Society on Thrombosis and Haemostasis (ISTH) 2022 Congress

09 July 2022 - 13 July 2022

Haemorrhagic complications in COVID-19 patients linked to mortality risk in ICU

Haemorrhagic complications in COVID-19 patients linked to in-ICU mortality risk

Roshini Claire Anthony, 20220816180001

A large global study of patients with severe COVID-19 admitted to the intensive care unit (ICU) has shown a 14 percent prevalence of haemorrhagic, coagulopathic, and thrombotic (HECTOR) complications in these patients, with mortality risk increased in those with haemorrhagic complications.

Heparin dose may not affect antepartum VTE incidence

VTE prevention in pregnancy: Does heparin dose matter?

Roshini Claire Anthony, 20220802180001

In pregnant women with a history of venous thromboembolism (VTE), receipt of low-molecular-weight heparin (LMWH) at either a weight-adjusted intermediate-dose or fixed low-dose during the antepartum and postpartum periods results in similar VTE incidence, according to findings of the Highlow study. However, there was a numerically lower incidence of VTE during the postpartum period with intermediate-dose LMWH.